Spyre Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $77.7M
Liabilities Breakdown FY2018
Total Liabilities: $10.3M
Asset Breakdown
Total Assets: $77.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $22.5M | 28.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.0M | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $54.3M | 69.8% |
Liabilities Breakdown
Total Liabilities: $10.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $663.0K | 6.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $9.6M | 93.6% |